X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-publishes-shareholder-update-letter-302186690.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-to-participate-in-the-hc-wainwright-5th-annual-neuro-perspectives-virtual-conference-on-june-27-2024-302177716.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-publishes-shareholder-update-letter-302168228.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-presents-landmark-trial-of-nrx-101-in-suicidal-bipolar-depression-at-the-american-society-of-clinical-psychopharmacology-annual-meeting-nrx-101-is-the-first-oral-antidepressant-demonstrated-to-re-302156419.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-reports-first-quarter-2024-financial-results-and-provides-business-update-302145361.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-to-participate-in-the-ef-hutton-annual-global-conference-on-may-15-2024-302139427.html
https://www.accesswire.com/860792/nrx-pharmaceuticals-eyes-first-commercial-revenue-in-2024-announces-breakthroughs-in-bi-annual-milestone-update
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-to-report-first-quarter-2024-financial-results-on-may-14-2024-302138776.html
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-final-clinical-trial-results-superior-safety-combined-with-similar-efficacy-in-the-trial-of-nrx-101-compared-to-lurasidone-in-suicidal-bipolar-depression-302136430.html
https://www.fiercebiotech.com/biotech/despite-trial-miss-nrx-pushes-antidepressant-forward-phase-3-patients-bipolar-depression
Market Place
Share 
